Fig. 3From: Bioactive adrenomedullin and interleukin-6 in COVID-19: potential biomarkers of acute kidney injury and critical illnessReceiver operating characteristic analysis of bio-ADM and IL-6 regarding the endpoint AKI in hospitalized patientsBack to article page